These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3196145)

  • 1. Biomonitoring of aromatic amines II: Hemoglobin binding of some monocyclic aromatic amines.
    Birner G; Neumann HG
    Arch Toxicol; 1988; 62(2-3):110-5. PubMed ID: 3196145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation.
    Sabbioni G
    Chem Biol Interact; 1992 Jan; 81(1-2):91-117. PubMed ID: 1730150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemoglobin binding in control of exposure to and risk assessment of aromatic amines.
    Neumann HG
    IARC Sci Publ; 1988; (89):157-65. PubMed ID: 3198198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring of arylamines: hemoglobin adducts of urea and carbamate pesticides.
    Sabbioni G; Neumann HG
    Carcinogenesis; 1990 Jan; 11(1):111-5. PubMed ID: 2295119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring of aromatic amines V: acetylation and deacetylation in the metabolic activation of aromatic amines as determined by haemoglobin binding.
    Zwirner-Baier I; Neumann HG
    Arch Toxicol; 1998; 72(8):499-504. PubMed ID: 9765065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomonitoring of aromatic amines. III: Hemoglobin binding of benzidine and some benzidine congeners.
    Birner G; Albrecht W; Neumann HG
    Arch Toxicol; 1990; 64(2):97-102. PubMed ID: 2350241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin binding of arylamines and nitroarenes: molecular dosimetry and quantitative structure-activity relationships.
    Sabbioni G
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):61-7. PubMed ID: 7889861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons.
    Riffelmann M; Müller G; Schmieding W; Popp W; Norpoth K
    Int Arch Occup Environ Health; 1995; 68(1):36-43. PubMed ID: 8847111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin binding of aromatic amines: molecular dosimetry and quantitative structure-activity relationships for N-oxidation.
    Sabbioni G
    Environ Health Perspect; 1993 Mar; 99():213-6. PubMed ID: 8319626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin binding of bicyclic aromatic amines.
    Sabbioni G; Schütze D
    Chem Res Toxicol; 1998 May; 11(5):471-83. PubMed ID: 9585478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hemoglobin as a dose monitor for alkylating and arylating agents.
    Neumann HG
    Arch Toxicol; 1984 Nov; 56(1):1-6. PubMed ID: 6517706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomonitoring of aniline and nitrobenzene. Hemoglobin binding in rats and analysis of adducts.
    Albrecht W; Neumann HG
    Arch Toxicol; 1985 Apr; 57(1):1-5. PubMed ID: 4015392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.
    Lewalter J; Korallus U
    Int Arch Occup Environ Health; 1985; 56(3):179-96. PubMed ID: 4066048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin binding of nitroarenes and quantitative structure-activity relationships.
    Sabbioni G
    Chem Res Toxicol; 1994; 7(2):267-74. PubMed ID: 8199317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dosimetry of aromatic amines in human populations.
    Skipper PL; Tannenbaum SR
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin adducts of N-substituted aryl compounds in exposure control and risk assessment.
    Neumann HG; Birner G; Kowallik P; Schütze D; Zwirner-Baier I
    Environ Health Perspect; 1993 Mar; 99():65-9. PubMed ID: 8319661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GC/MS analysis of biologically important aromatic amines. Application to human dosimetry.
    Stillwell WG; Bryant MS; Wishnok JS
    Biomed Environ Mass Spectrom; 1987 May; 14(5):221-7. PubMed ID: 2955825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring of aromatic amines and alkylating agents by measuring hemoglobin adducts.
    Neumann HG
    Int Arch Occup Environ Health; 1988; 60(3):151-5. PubMed ID: 3384479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of hemoglobin adducts of arylamines in humans.
    Sabbioni G; Beyerbach A
    J Chromatogr B Biomed Appl; 1995 May; 667(1):75-83. PubMed ID: 7663688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemoglobin Adducts and Urinary Metabolites of Arylamines and Nitroarenes.
    Sabbioni G
    Chem Res Toxicol; 2017 Oct; 30(10):1733-1766. PubMed ID: 28933159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.